ID

22007

Beschreibung

Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features; ODM derived from: https://clinicaltrials.gov/show/NCT00585585

Link

https://clinicaltrials.gov/show/NCT00585585

Stichworte

Versionen (1)
  1. 14.05.17 14.05.17 -
Hochgeladen am

14. Mai 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Major Depression, Atypical Features NCT00585585

Englisch

Eligibility Major Depression, Atypical Features NCT00585585

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. have signed written informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
2. be male and/or female outpatients 18 65 years of age, inclusive
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
3. for women: must be surgically sterile, 2 years postmenopausal, or, if they have childbearing potential, using a medically accepted method of birth control and agree to continue use of this method for at least 30 days after the last dose of study drug (i.e., barrier method with spermicide, steroidal contraceptive or intrauterine device [iud])
Beschreibung

effective contraception

Datentyp

boolean

Alias
UMLS CUI [1]
C0700589
4. meet dsm iv1 criteria for major depressive episode (unipolar), with atypical features
Beschreibung

major depressive episode with atypical features

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0520669
UMLS CUI [1,2]
C0220952
5. have a score of 20 or greater on the hamilton depression rating, 28-item version (ham-d-28)
Beschreibung

hamilton depression rating scale

Datentyp

boolean

Alias
UMLS CUI [1]
C0451203
6. have a complete medical and psychiatric history, physical examination, laboratory evaluation, and ecg before study entry.
Beschreibung

medical and psychiatric history, physical examination, laboratory, ecg

Datentyp

boolean

Alias
UMLS CUI [1]
C0262926
UMLS CUI [2]
C0748059
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0022877
UMLS CUI [5]
C1623258
7. have baseline laboratory values and ecg that are normal, or abnormalities that are clinically insignificant
Beschreibung

laboratory, ecg

Datentyp

boolean

Alias
UMLS CUI [1]
C0022877
UMLS CUI [2]
C1623258
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. have significant and/or unstable gastrointestinal, neurological, endocrine, cardiovascular, pulmonary, renal, hepatic, immunological or hematological disease; organic brain disease; or cancer as determined by history, physical, ecg, and laboratory examination
Beschreibung

gastrointestinal, neurological, endocrine, cardiovascular, pulmonary, renal, hepatic, immunological, hematolgical, organic brain disease, cancer

Datentyp

boolean

Alias
UMLS CUI [1]
C0017178
UMLS CUI [2]
C0027765
UMLS CUI [3]
C0014130
UMLS CUI [4]
C0007222
UMLS CUI [5]
C0024115
UMLS CUI [6]
C0022658
UMLS CUI [7]
C0023895
UMLS CUI [8]
C00210533
UMLS CUI [9]
C0018939
UMLS CUI [10,1]
C0006111
UMLS CUI [10,2]
C0747055
UMLS CUI [11]
C0006826
2. have a history of peptic ulcer disease
Beschreibung

peptic ulcer disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0030920
3. have a history of severe asthma
Beschreibung

asthma

Datentyp

boolean

Alias
UMLS CUI [1]
C0004096
4. have a current diagnosis of pheochromocytoma
Beschreibung

pheochromocytoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0031511
5. are pregnant, intending to become pregnant, nursing, at risk for pregnancy, or not practicing medically acceptable birth control. (a blood pregnancy test will be performed at the screening visit)
Beschreibung

pregnancy, breast feeding, effective contraception, pregnancy test

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
UMLS CUI [4]
C0032976
6. meet criteria for dsm iv1 psychoactive substance abuse or dependence in the past month
Beschreibung

substance use disorders dsm iv

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0220952
7. have a history of a psychotic disorder
Beschreibung

psychotic disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C0033975
8. use any medications that, in the judgment of the investigator, might have psychotropic effects, or interact unfavorably with betahistine dihydrochloride including centrally acting antihistaminic agents
Beschreibung

psychotropic drugs, interaction with betahistine dihydrochloride

Datentyp

boolean

Alias
UMLS CUI [1]
C0033978
UMLS CUI [2,1]
C0687133
UMLS CUI [2,2]
C0282071
9. have a history of hypersensitivity to betahistine dihydrochloride
Beschreibung

betahistine dihydrochloride hypersensitivity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0282071
UMLS CUI [1,2]
C0020517
10. exhibit, or suggestion that they may display, behavior that will not be conducive to the study procedures
Beschreibung

compliance behaviour

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
11. are at significant risk of suicide as indicated by a score of 3 or greater on item number 11 on the ham-d 28
Beschreibung

suicide risk

Datentyp

boolean

Alias
UMLS CUI [1]
C1271074
12. have received any investigational product within 28 days of screening
Beschreibung

investigational drug

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
13. have used any antidepressant within 7 days of screening (14 days for maois; 21 days for fluoxetine)
Beschreibung

antidepressants

Datentyp

boolean

Alias
UMLS CUI [1]
C0003289
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Major Depression, Atypical Features NCT00585585

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
1. have signed written informed consent
boolean
C0021430 (UMLS CUI [1])
age
Item
2. be male and/or female outpatients 18 65 years of age, inclusive
boolean
C0001779 (UMLS CUI [1])
effective contraception
Item
3. for women: must be surgically sterile, 2 years postmenopausal, or, if they have childbearing potential, using a medically accepted method of birth control and agree to continue use of this method for at least 30 days after the last dose of study drug (i.e., barrier method with spermicide, steroidal contraceptive or intrauterine device [iud])
boolean
C0700589 (UMLS CUI [1])
major depressive episode with atypical features
Item
4. meet dsm iv1 criteria for major depressive episode (unipolar), with atypical features
boolean
C0520669 (UMLS CUI [1,1])
C0220952 (UMLS CUI [1,2])
hamilton depression rating scale
Item
5. have a score of 20 or greater on the hamilton depression rating, 28-item version (ham-d-28)
boolean
C0451203 (UMLS CUI [1])
medical and psychiatric history, physical examination, laboratory, ecg
Item
6. have a complete medical and psychiatric history, physical examination, laboratory evaluation, and ecg before study entry.
boolean
C0262926 (UMLS CUI [1])
C0748059 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0022877 (UMLS CUI [4])
C1623258 (UMLS CUI [5])
laboratory, ecg
Item
7. have baseline laboratory values and ecg that are normal, or abnormalities that are clinically insignificant
boolean
C0022877 (UMLS CUI [1])
C1623258 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
gastrointestinal, neurological, endocrine, cardiovascular, pulmonary, renal, hepatic, immunological, hematolgical, organic brain disease, cancer
Item
1. have significant and/or unstable gastrointestinal, neurological, endocrine, cardiovascular, pulmonary, renal, hepatic, immunological or hematological disease; organic brain disease; or cancer as determined by history, physical, ecg, and laboratory examination
boolean
C0017178 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
C0014130 (UMLS CUI [3])
C0007222 (UMLS CUI [4])
C0024115 (UMLS CUI [5])
C0022658 (UMLS CUI [6])
C0023895 (UMLS CUI [7])
C00210533 (UMLS CUI [8])
C0018939 (UMLS CUI [9])
C0006111 (UMLS CUI [10,1])
C0747055 (UMLS CUI [10,2])
C0006826 (UMLS CUI [11])
peptic ulcer disease
Item
2. have a history of peptic ulcer disease
boolean
C0030920 (UMLS CUI [1])
asthma
Item
3. have a history of severe asthma
boolean
C0004096 (UMLS CUI [1])
pheochromocytoma
Item
4. have a current diagnosis of pheochromocytoma
boolean
C0031511 (UMLS CUI [1])
pregnancy, breast feeding, effective contraception, pregnancy test
Item
5. are pregnant, intending to become pregnant, nursing, at risk for pregnancy, or not practicing medically acceptable birth control. (a blood pregnancy test will be performed at the screening visit)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0032976 (UMLS CUI [4])
substance use disorders dsm iv
Item
6. meet criteria for dsm iv1 psychoactive substance abuse or dependence in the past month
boolean
C0038586 (UMLS CUI [1,1])
C0220952 (UMLS CUI [1,2])
psychotic disorder
Item
7. have a history of a psychotic disorder
boolean
C0033975 (UMLS CUI [1])
psychotropic drugs, interaction with betahistine dihydrochloride
Item
8. use any medications that, in the judgment of the investigator, might have psychotropic effects, or interact unfavorably with betahistine dihydrochloride including centrally acting antihistaminic agents
boolean
C0033978 (UMLS CUI [1])
C0687133 (UMLS CUI [2,1])
C0282071 (UMLS CUI [2,2])
betahistine dihydrochloride hypersensitivity
Item
9. have a history of hypersensitivity to betahistine dihydrochloride
boolean
C0282071 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
compliance behaviour
Item
10. exhibit, or suggestion that they may display, behavior that will not be conducive to the study procedures
boolean
C1321605 (UMLS CUI [1])
suicide risk
Item
11. are at significant risk of suicide as indicated by a score of 3 or greater on item number 11 on the ham-d 28
boolean
C1271074 (UMLS CUI [1])
investigational drug
Item
12. have received any investigational product within 28 days of screening
boolean
C0013230 (UMLS CUI [1])
antidepressants
Item
13. have used any antidepressant within 7 days of screening (14 days for maois; 21 days for fluoxetine)
boolean
C0003289 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video